Simcere Pharmaceutical Group 先声药业集团 ; 先声药业
Simcere Pharmaceutical 先声药业 ; 南京先声
Simcere Pharm 先声药业
Shandong Simcere-Medgenn Bio-pharmaceutical Co 山东先声麦得津生物制药有限公司
Simcere bought Endu, an innovative cancer drug, in 2006, prior to the IPO.
先声在2006年上市之前就收购一个创新性的抗癌药：恩度。
Simcere calls Bicun a "first-to-market, branded generic drug." Edaravone has been investigated heavily in Japan for use as a neuroprotectant.
先声称必存为“市场第一，品牌的仿制药。”在日本，对依达拉奉作为一种神经保护剂进行了大量研究。
I tend to like the smaller, overseas-listed companies like Simcere as they are often more entrepreneurial and adaptable to market conditions.
我比较倾向于较小、海外上市的企业，如先声药业，因为这些企业往往更具闯劲，更能灵活应变市场状况。
应用推荐